Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes MellitusA Matching-Adjusted Indirect Comparison of Randomized Trials

被引：0

作者：

James E. Signorovitch

Eric Q. Wu

Elyse Swallow

Evan Kantor

Liangyi Fan

Jean-Bernard Gruenberger

机构：

[1] Analysis Group,

[2] Inc.,undefined

[3] Novartis Pharma AG,undefined

来源：

Clinical Drug Investigation | 2011年 / 31卷

关键词：

Fasting Plasma Glucose; Glycaemic Control; Sitagliptin; Vildagliptin; Individual Patient Data;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background and Objective: Vildagliptin and sitagliptin are oral dipeptidyl peptidase 4 inhibitors approved in Japan for the treatment of type 2 diabetes mellitus when adequate glycaemic control is not achieved with diet, exercise or sulphonylureas. The aim of this study was to compare 12-week glycaemic control with vildagliptin 50 mg twice daily versus sitagliptin 50 or 100 mg once daily in Japanese patients with type 2 diabetes.

引用

页码：665 / 674

页数：9

共 50 条

[41] Serum C-peptide to plasma glucose ratio may be associated with efficacy of vildagliptin in Japanese patients with type 2 diabetes mellitus
Tanaka M.
Sekioka R.
Nishimura T.
Kawai T.
Meguro S.
Irie J.
Saisho Y.
Itoh H.
Diabetology International, 2015, 6 (3) : 197 - 205
[42] Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
Vilsboll, T.
Rosenstock, J.
Yki-Jarvinen, H.
Cefalu, W. T.
Chen, Y.
Luo, E.
Musser, B.
Andryuk, P. J.
Ling, Y.
Kaufman, K. D.
Amatruda, J. M.
Engel, S. S.
Katz, L.
DIABETES OBESITY & METABOLISM, 2010, 12 (02) : 167 - 177
[43] Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
Raz, Itamar
Chen, Yu
Wu, Mei
Hussain, Shehla
Kaufman, Keith D.
Amatruda, John M.
Langdon, Ronald B.
Stein, Peter P.
Alba, Maria
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 537 - 550
[44] Efficacy and safety of sitagliptin in patients with type 2 diabetes mellitus: a meta-analysis
Zhao, Jun-Yu
Wang, Hai-Peng
Wang, Huan-Jun
Yao, Jin-Ming
Wu, Xiao-Yun
Dong, Jian-Jun
Liao, Lin
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11202 - 11210
[45] Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea
Mohan, Viswanathan
Yang, Wenying
Son, Ho-Young
Xu, Lei
Noble, Liliane
Langdon, Ronald B.
Amatruda, John M.
Stein, Peter P.
Kaufman, Keith D.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 106 - 116
[46] Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial
Masato Odawara
Mika Yoshiki
Misako Sano
Izumi Hamada
Valentina Lukashevich
Wolfgang Kothny
Diabetes Therapy, 2015, 6 : 17 - 27
[47] Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial
Odawara, Masato
Yoshiki, Mika
Sano, Misako
Hamada, Izumi
Lukashevich, Valentina
Kothny, Wolfgang
DIABETES THERAPY, 2015, 6 (01) : 17 - 27
[48] Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study
Takahisa Hirose
Manabu Suzuki
Isao Tsumiyama
Diabetes Therapy, 2015, 6 : 559 - 571
[49] The efficacy and safety of luseogliflozin and sitagliptin depending on the sequence of administration in patients with type 2 diabetes mellitus: a randomized controlled pilot study
Takihata, Masahiro
Terauchi, Yasuo
EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (17) : 2185 - 2194
[50] Efficacy of sitagliptin on blood glucose fluctuation in Japanese type 2 diabetic patients with basal-supported oral therapy
Takahara, Mitsuyoshi
Shiraiwa, Toshihiko
Kaneto, Hideaki
Katakami, Naoto
Matsuoka, Taka-aki
Shimomura, Iichiro
ENDOCRINE JOURNAL, 2012, 59 (12) : 1131 - 1136

← 1 2 3 4 5 →